Matyas Lakatos is a seasoned biopharma executive with an MD and MBA, known for building multi-billion-dollar franchises from first-in-class science.
He has spearheaded innovative launches in chronic disease and specialty care, establishing new therapeutic categories and market pathways.
He’s a global expert on incretins (GLP-1s), obesity and the cardiometabolic space.
Veritux independent consultants are available where you need them – in all major markets and every global region.
